GB8724564D0 - Therapeutic compounds - Google Patents
Therapeutic compoundsInfo
- Publication number
- GB8724564D0 GB8724564D0 GB878724564A GB8724564A GB8724564D0 GB 8724564 D0 GB8724564 D0 GB 8724564D0 GB 878724564 A GB878724564 A GB 878724564A GB 8724564 A GB8724564 A GB 8724564A GB 8724564 D0 GB8724564 D0 GB 8724564D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57527—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878724564A GB8724564D0 (en) | 1987-10-20 | 1987-10-20 | Therapeutic compounds |
GB9024046A GB2237000B (en) | 1986-10-21 | 1987-10-20 | A container |
AU25577/88A AU612428B2 (en) | 1987-10-20 | 1988-10-20 | Cgrp for cerebral blood supply improvement |
EP88909111A EP0344239A1 (en) | 1987-10-20 | 1988-10-20 | Cgrp for cerebral blood supply improvement |
JP63508432A JPH02502011A (en) | 1987-10-20 | 1988-10-20 | Therapeutic compounds, compositions and their uses |
PCT/GB1988/000877 WO1989003686A1 (en) | 1987-10-20 | 1988-10-20 | Cgrp for cerebral blood supply improvement |
DK301489A DK301489D0 (en) | 1987-10-20 | 1989-06-19 | CGRP FOR USE TO IMPROVE CEREBRAL BLOOD SUPPLY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878724564A GB8724564D0 (en) | 1987-10-20 | 1987-10-20 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8724564D0 true GB8724564D0 (en) | 1987-11-25 |
Family
ID=10625611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB878724564A Pending GB8724564D0 (en) | 1986-10-21 | 1987-10-20 | Therapeutic compounds |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0344239A1 (en) |
JP (1) | JPH02502011A (en) |
AU (1) | AU612428B2 (en) |
DK (1) | DK301489D0 (en) |
GB (1) | GB8724564D0 (en) |
WO (1) | WO1989003686A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990004605A1 (en) * | 1988-10-20 | 1990-05-03 | Celltech Limited | Calcitonin gene related peptide analogues |
KR950007873A (en) * | 1993-09-20 | 1995-04-15 | 후꾸하라 요시하루 | Biologics Sustained-Release Pharmaceutical Formulations |
WO2009039963A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
-
1987
- 1987-10-20 GB GB878724564A patent/GB8724564D0/en active Pending
-
1988
- 1988-10-20 AU AU25577/88A patent/AU612428B2/en not_active Ceased
- 1988-10-20 WO PCT/GB1988/000877 patent/WO1989003686A1/en not_active Application Discontinuation
- 1988-10-20 JP JP63508432A patent/JPH02502011A/en active Pending
- 1988-10-20 EP EP88909111A patent/EP0344239A1/en not_active Withdrawn
-
1989
- 1989-06-19 DK DK301489A patent/DK301489D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2557788A (en) | 1989-05-23 |
DK301489A (en) | 1989-06-19 |
AU612428B2 (en) | 1991-07-11 |
DK301489D0 (en) | 1989-06-19 |
JPH02502011A (en) | 1990-07-05 |
EP0344239A1 (en) | 1989-12-06 |
WO1989003686A1 (en) | 1989-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8719367D0 (en) | Therapeutic compounds | |
EP0310386A3 (en) | Therapeutic agents | |
GB8725939D0 (en) | Therapeutic compounds | |
EP0279598A3 (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds | |
EP0302831A3 (en) | Compounds | |
GB8716975D0 (en) | Therapeutic agents | |
GB8801274D0 (en) | Therapeutic agents | |
GB8727792D0 (en) | Therapeutic agents | |
GB8709327D0 (en) | Compounds | |
GB8724564D0 (en) | Therapeutic compounds | |
GB8603447D0 (en) | Therapeutic compounds | |
GB8722477D0 (en) | Compounds | |
GB8721342D0 (en) | Therapeutic agents | |
GB8721343D0 (en) | Therapeutic agents | |
GB8701811D0 (en) | Compounds | |
GB8603449D0 (en) | Therapeutic compounds | |
GB8725220D0 (en) | Therapeutic use | |
IE870521L (en) | Therapeutic agents | |
GB8720939D0 (en) | Therapeutic agents | |
GB8729925D0 (en) | Therapeutic agents | |
GB8729926D0 (en) | Therapeutic agents | |
GB8727990D0 (en) | Therapeutic agents | |
GB8725577D0 (en) | Therapeutic agents | |
GB8722977D0 (en) | Therapeutic agents | |
IE872942L (en) | Therapeutic agents |